Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX

Haemophilia. 2017 May;23(3):e222-e224. doi: 10.1111/hae.13195. Epub 2017 Mar 30.

¹ Division of Haematology/Oncology, Department of Paediatrics, Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
² CHCMN Hemophilia and Thrombosis Center Children's Hospital and Clinics of Minnesota, Minneapolis, MN, USA.
³ Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy.
⁴ Department of Haemophilia, Haemostasis and Thrombosis, Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, UK.
⁵ School of Rural and Northern Health and ECHO Research Centre, Laurentian University, Sudbury, ON, Canada.
⁶ Mapi, Patient-Centered Outcomes, Lyon, France.
⁷ Novo Nordisk A/S, Søborg, Denmark.

No abstract available

Publication types